Oxcarbazepine for Panic Disorder Occurring After Two Grand Mal Seizures: A Case Report
J Clin Psychiatry 1997;58:404-405 [letter]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Letter to the Editor
Sir: Recently, pathophysiologic relations between panic disorder
and epilepsy, at least in a subgroup of patients, have been
hypothesized, and thus the rational use of anticonvulsants in panic disorder has been proposed. Several preliminary non-placebo-
controlled studies used carbamazepine successfully in
panic disorder, even though one non-placebo-controlled study
found carbamazepine ineffective. Oxcarbazepine (Trileptal) is
a new anticonvulsant substance with a chemical structure related
to that of carbamazepine but with quite different metabolic
pathways and active metabolites. Oxcarbazepine has not been
studied in panic disorder yet. We present a patient who developed
panic disorder after suffering from two grand mal seizures
and in whom both conditions were relieved by oxcarbazepine.